Good news today for PTIE and it couldn't have happened to a nicer crowd of people too:-
"Pfizer Halts Inotuzumab Study"
PFE may have to press on reluctantly with Remoxy as their continuing list of pipeline failures just keeps growing :)
Don't even let them in the door Remi. Just play hardball and tell them to get on with it and shorten the likely NDA timescale by 6 months or so or you may have to sue them for breach of contract. They are wasting valuable time as we speak.
Agreed. Pfizer needs a strong presence in pain to keep its' stock price up. Endo needs pain drugs even more. Drugs with a clear path forward in a growing indication with a long patent life and barriers to entry are hard to come by.